Skip to main content
. 2020 Sep 7;91(3):e2020014. doi: 10.23750/abm.v91i3.10303

Table 2.

Cumulative prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity recurrence with nucleic acid amplification test (NAAT) in specific settings

Setting Prevalence Heterogeneity
Excluding Cento et al. 0.14 (95% CI, 0.13-0.16) I2, 64%
Only respiratory tract specimens 0.13 (95% CI 0.12-0.14%) I2, 79%
Studies outside China 0.11 (95% CI, 0.10-0.12) I2, 80%